Asset Details
Do you wish to reserve the book?
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Do you wish to request the book?
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
2016
Overview
Ebola virus causes a devastating clinical illness that is associated with high mortality. In this trial conducted primarily in West Africa during an outbreak, ZMapp (a cocktail of three monoclonal antibodies against Ebola) showed some clinical activity.
The 2014–2016 Ebola outbreak in West Africa was unprecedented in sheer scope, duration, and number of human casualties.
1
,
2
The outbreak resulted in more than 28,000 suspected or confirmed cases of Ebola virus disease (EVD) and more than 11,000 deaths.
3
Fragile health care infrastructures that were often already severely compromised by past years of civil strife played a substantial role in the propagation of the outbreak. Although the final postmortem analysis of the global response has yet to be written, there can be little doubt that the lack of therapeutic agents and vaccines with proven efficacy against EVD further contributed . . .
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Antibodies, Monoclonal - adverse effects
/ Antibodies, Monoclonal - therapeutic use
/ Child
/ Ebolavirus - isolation & purification
/ Female
/ Hemorrhagic Fever, Ebola - drug therapy
/ Hemorrhagic Fever, Ebola - mortality
/ Hemorrhagic Fever, Ebola - therapy
/ Hemorrhagic Fever, Ebola - virology
/ Humans
/ Male
/ Patients
